Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARNA | AMGN | VRTX | REGN | BMY |
| Company | Arena Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 99.97 | 277.69 | 402.95 | 900.00 | 44.36 |
| High | 100.00 | 278.52 | 403.92 | 921.51 | 44.42 |
| Low | 99.97 | 275.10 | 398.46 | 891.30 | 43.33 |
| Last | 99.99 | 277.69 | 401.48 | 920.33 | 43.89 |
| Change | +0.06 | +0.32 | -0.66 | +16.85 | -0.32 |
| % Change | +0.06% | +0.12% | -0.16% | +1.87% | -0.72% |
| Volume | 5,718,500 | 554,274 | 253,500 | 239,129 | 4,869,062 |
| 20-Day Average Volume | 1,676,465 | 2,145,809 | 963,720 | 467,078 | 13,749,812 |
| Previous Close | 99.93 | 277.37 | 402.14 | 903.48 | 44.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 94.81 | 270.16 | 398.78 | 908.01 | 47.84 |
| 20-Day Raw Stochastic | 99.86% | 87.63% | 55.31% | 52.87% | 5.71% |
| 20-Day Relative Strength | 75.07% | 52.88% | 47.31% | 47.00% | 27.76% |
| Weighted Alpha | -14.40 | +14.61 | +14.51 | +19.15 | -36.98 |
| Today's Opinion | 100% Buy | 24% Sell | 8% Buy | 24% Buy | 88% Sell |
| Previous Opinion | 100% Buy | 24% Sell | 8% Buy | 8% Buy | 88% Sell |
| Last Month's Opinion | 100% Buy | 8% Sell | 40% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.34% since 03/03/22 | +3.00% since 04/25/24 | +0.95% since 04/25/24 | +2.69% since 04/25/24 | -1.94% since 04/25/24 |
| Low | 93.54 on 03/07/22 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.36 on 05/02/24 |
| High | 100.00 on 03/10/22 | 279.84 on 05/01/24 | 406.95 on 05/01/24 | 921.51 on 05/02/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | +6.37% since 02/10/22 | +0.46% since 04/02/24 | -1.94% since 04/02/24 | -4.19% since 04/02/24 | -16.88% since 04/02/24 |
| Low | 92.85 on 02/22/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.36 on 05/02/24 |
| High | 100.00 on 03/10/22 | 279.84 on 05/01/24 | 414.95 on 04/03/24 | 962.20 on 04/04/24 | 52.87 on 04/03/24 |
| 3-Month | |||||
| %Chg | +100.22% since 12/10/21 | -14.15% since 02/02/24 | -5.46% since 02/02/24 | -3.23% since 02/02/24 | -10.01% since 02/02/24 |
| Low | 89.03 on 01/25/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.36 on 05/02/24 |
| High | 100.00 on 03/10/22 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +68.36% since 09/10/21 | +4.08% since 11/02/23 | +6.62% since 11/02/23 | +11.71% since 11/02/23 | -14.27% since 11/02/23 |
| Low | 48.12 on 12/06/21 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.36 on 05/02/24 |
| High | 100.00 on 03/10/22 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,165,283 | 148,774,592 | 103,936,712 | 99,167,768 | 89,618,088 |
| Shares Outstanding, K | 61,659 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 50,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -616,430,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 50,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -155,610,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.55 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.54 on 02/23/22 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/04/22 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.69 | 29.23 | 23.70 | 41.85 |